Identifying Biological Signatures of Disease
AI-driven biomarker discovery is identifying molecular signatures that indicate disease presence, progression, or treatment response. These biomarkers enable earlier diagnosis, better patient stratification, and more effective treatment monitoring.
AI analyzes diverse data types including genomics, proteomics, metabolomics, and imaging to identify biomarker panels that provide robust disease signatures more accurate than single biomarkers.
Machine learning models identify biomarkers that predict treatment response, enabling selection of therapies most likely to benefit individual patients and avoiding ineffective treatments.
AI interprets circulating tumor DNA, proteins, and other analytes in blood samples to detect cancer early, monitor treatment response, and identify resistance mechanisms.
Join our upcoming conferences and connect with leading experts in pharmaceutical AI